Literature DB >> 9629328

[Autonomic neuropathy in patients with impaired glucose tolerance].

K F Rezende1, A Melo, J Pousada, Z F Rezende, N L Santos, I Gomes.   

Abstract

UNLABELLED: Impaired glucose tolerance (IGT) is a clinical situation characterized by mild hyperglycemia, which is estimated to afflict 7.8% of the Brazilian population. Diabetic neuropathy is the most common complication in diabetes mellitus and it is related to morbidity and lethality in this disease. The association between IGT and peripheral neuropathy is still a matter of great concern. PURPOSE AND
METHOD: In order to determine if IGT is associated with autonomic neuropathy a cross-sectional study in 44 patients with impaired glucose tolerance test (Group 1) was performed. The patients were compared to 43 control individuals (Group 2). Every patient in each group underwent anamnesis and standardized autonomic tests which consisted of heart frequency test, Valsalva maneuver, postural test and sinus arrhythmia. Routine hematologic exams as well as GTT were also made.
RESULTS: Patients in group 1 had more systemic arterial hypertension, centripetal obesity, fasting and post-feeding hyperglycemia and dyslipidemia when compared with group 2. When we analysed the autonomic tests, the sinus arrhythmia test was abnormal in 54.5% of the patients in group 1 and in 32.5% in group 2 (p = 0.0039) and the Valsalva maneuver was abnormal in 34.1% of group 1 and in 7% of group 2 (p = 0.004). The postural test was not different in both groups (p = 0.334).
CONCLUSION: Our results show that the involvement of the autonomic nervous system was more frequent in patients with IGT when compared to controls. These findings can explain the increased lethality due to vasculopathies observed in this group of patients and also alert physicians to care for patients with impaired glucose tolerance test.

Entities:  

Mesh:

Year:  1997        PMID: 9629328     DOI: 10.1590/s0004-282x1997000500005

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  4 in total

1.  Impaired glycemia and diabetic polyneuropathy: the OC IG Survey.

Authors:  Peter J Dyck; Vicki M Clark; Carol J Overland; Jenny L Davies; John M Pach; P James B Dyck; Christopher J Klein; Robert A Rizza; L Joseph Melton; Rickey E Carter; Ronald Klein; William J Litchy
Journal:  Diabetes Care       Date:  2012-03       Impact factor: 19.112

Review 2.  Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.

Authors:  F Brucker-Davis; K Thayer; T Colborn
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

3.  Increased Short-Term Beat-to-Beat QT Interval Variability in Patients with Impaired Glucose Tolerance.

Authors:  Andrea Orosz; István Baczkó; Szabolcs Nyiraty; Anna E Körei; Zsuzsanna Putz; Róbert Takács; Attila Nemes; Tamás T Várkonyi; László Balogh; György Ábrahám; Péter Kempler; Julius Gy Papp; András Varró; Csaba Lengyel
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-13       Impact factor: 5.555

4.  Cardiac autonomic nervous dysfunction detected by both heart rate variability and heart rate turbulence in prediabetic patients with isolated impaired fasting glucose.

Authors:  Akif Serhat Balcıoğlu; Sinan Akıncı; Davran Çiçek; Ali Çoner; Uğur Abbas Bal; İbrahim Haldun Müderrisoğlu
Journal:  Anatol J Cardiol       Date:  2016-03-23       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.